ctrl K

Watchlist Price Alert

Avidity Biosciences Inc. (RNA)

NASDAQ: RNA · Real-Time Price · USD

28.47

-1.41 (-4.72%)

At close: May 14, 2025, 3:59 PM

Avidity Biosciences Revenue Breakdown

Period Ending	Dec 31, 2024
Reportable Segment Revenue	10.9M
Reportable Segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	28.34M	23.27M	20.73M	13.26M	15.5M	13.73M	12.28M	12.06M	10.38M	10.09M	8.69M	8.57M	7.43M	6.61M	6.27M	5.88M	4.82M	3.76M	2.92M	1.96M	1.85M	757K	1.6M	912K
Selling, General, and Administrative Revenue Growth	+21.76%	+12.26%	+56.38%	-14.49%	+12.93%	+11.82%	+1.77%	+16.18%	+2.87%	+16.18%	+1.41%	+15.29%	+12.39%	+5.49%	+6.53%	+22.18%	+28.19%	+28.44%	+48.93%	+6.33%	+143.99%	-52.57%	+75.00%	n/a
Research and Development Revenue	95.63M	77.2M	63.94M	66.83M	52.82M	47.71M	42.67M	47.77M	45.61M	37.32M	39.79M	27.69M	32.97M	24.83M	22.71M	20.68M	13.62M	9.46M	8.98M	5.54M	5.64M	5.1M	2.53M	1.26M
Research and Development Revenue Growth	+23.87%	+20.73%	-4.33%	+26.54%	+10.69%	+11.82%	-10.66%	+4.72%	+22.22%	-6.21%	+43.70%	-16.02%	+32.77%	+9.36%	+9.81%	+51.82%	+44.04%	+5.24%	+62.05%	-1.79%	+10.71%	+101.30%	+100.71%	n/a